Chemical Dependency and Smoking Cessation: Patient's Views - 1

NCT00051883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to asses patient views on smoking cessation and tobacco harm reduction during drug treatment.

Conditions

  • Tobacco Use Disorder

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Kimber Richter, Ph.D. · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-12-31
Completion
2005-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00051883 on ClinicalTrials.gov